Top Coronavirus Doctor in Wuhan Says High Blood Pressure Is Major Death Risk

(Bloomberg) --

Patients with hypertension appear to be at a higher risk of dying from the coronavirus, said a top Chinese intensive care doctor who's been treating critically ill patients since mid-January.

While there's been no published research yet explaining why, Chinese doctors working in Wuhan, the central Chinese city where the virus first emerged, have noticed that infected patients with that underlying illness are more likely to slip into severe distress and die.

Of a group of 170 patients who died in January in Wuhan -- the first wave of casualties caused by a pathogen that's now raced around the world -- nearly half had hypertension.

“That's a very high ratio,” said Du Bin, director of the intensive care unit at Peking Union Medical College Hospital, in an interview with Bloomberg over the phone from Wuhan. He was among a team of top doctors sent to the devastated city two months ago to help treat patients there.

“From what I was told by other doctors and the data I can see myself, among all the underlying diseases, hypertension is a key dangerous factor,” said Du, one of the most respected critical care experts in China. “Though there is no research published on that yet, we believe hypertension could be an important factor in causing patients to deteriorate, leading to a bad prognosis.”

Read more on how the virus reaches a fatal “tipping point” when lungs become inflamed

As the outbreak picks up speed in Europe and the U.S., plunging countries like Italy into crisis, doctors are struggling to treat the highly-infectious pathogen that's infected over 108,000 people globally in just three months.

Understanding the course of the disease and identifying individuals at greatest risk are critical for optimizing care for a global contagion that's killed more than 3,700 people since emerging in China in December.

Answers may lie in studying the large pool of patients in China, where more than 15,000 remain hospitalized although new infections have slowed dramatically. The disease turns critical in 6% of patients and deterioration can happen very quickly.

“We'll keep an eye on old people and those with high blood pressure. They are the key focus,” said Du.

Besides the hypertension factor, Du's other insights into treating the disease are:

Move Aggressively to Ventilate

Du said that doctors should not hesitate to escalate measures for patients facing respiratory distress, as organ failure can set in quickly after. That means doctors should intervene aggressively with invasive ventilation measures -- inserting a tube into a patient's throat or cutting the throat open to create an airway -- when low blood oxygen levels can't be improved by less invasive measures.

Almost half of the patients who require invasive mechanical ventilation end up dying, but most of those who recover are those who were put on invasive ventilation early, said Du.

“Patients need to use invasive ventilation as early as possible, there's no point of doing it late,” he said.

Respiratory therapists -- doctors that specialize in ventilation and oxygen treatment -- are becoming all the more important in treating patients critically ill with Covid-19 as they are more knowledgeable and can fine-tune ventilators to suit patient conditions.

No ‘Magic Bullets' in Drugs

There is growing anticipation over drugs being developed to treat the virus, with investors adding billions to the market value of pharmaceutical companies testing treatments now. But Du said drugs alone cannot save patients, especially those in severe condition.

Read more on how the search for coronavirus drug faces long odds

The experience of SARS, the epidemic 17 years ago that sickened almost 8,000 people, showed that most patients can be cured without a specific anti-viral drug, said Du. And the abundance of antibiotics has not prevented deaths by bacterial infections, he added.

“When there's a virus infection, we hope there's a drug that can kill the virus and change the clinical outcome. But there's no magic bullet.”

Instead, teamwork among specialists and nurses in intensive care units can be more crucial in keeping patients alive, he said. “An ICU doctor should work like a conductor in an orchestra to provide life-sustaining treatment while taking into consideration different specialist views,” he said.

Threat of Re-infection

Reports that people who have recovered and been discharged from hospital later test positive again -- and even die from the disease -- have ignited fears that the virus can somehow re-emerge.

Du said that patients becoming re-infected again within days of leaving the hospital makes no sense “theoretically” as the anti-bodies in their bloodstream generated from fighting the disease do not disappear so quickly, although they don't necessarily stay forever.

“What we need to look at in terms of those who tested positive again is concerns over the authenticity of their negative results,” he said. For example, samples taken from different areas of the same patient could test differently depending on where the virus resides.

Test kits made by different manufacturers could also have inconsistencies that impact test results, he said.

Mild Impact on Pregnant Women, Children

Despite their seeming physical vulnerability, pregnant women and children do not seem to be affected by the coronavirus in a serious manner, Du said. This is in contrast to other viruses like influenza.

“From what we known, infected pregnant women do not get into a serious situation with the coronavirus,” Du said. “With influenza, pregnancy is a high risk factor that can cause severe symptoms and lead to bad outcomes, but not this time.”

Children infected with the coronavirus also seem to experience only mild symptoms, said Du. He has not seen any child infections deteriorate to a state which requires intensive care.

To contact Bloomberg News staff for this story: Dong Lyu in Beijing at dlyu3@bloomberg.net;Claire Che in Beijing at yche16@bloomberg.net

To contact the editors responsible for this story: Rachel Chang at wchang98@bloomberg.net, Sharon Chen

©2020 Bloomberg L.P.

With assistance from Bloomberg